Quote | Super Quote
IPO   |   IPO News   |   Listed IPO Information   |   Hot Listed IPO
Stock Code   IPO News IPO Timetable
IPO Detail
02228 QUANTUMPH-P
QUANTUMPH-P
Listing Date2024/06/13
Listing Price5.280
 
Quote
Subscription Result
  • Subscription Rate
    103.35x
  • Guarantee One Lot Size
    15 lot
  • One Lot Success Rate
    20%
COMPANY PROFILE

QuantumPharm Inc. is a quantum physics-based, AI-powered, and robotics-driven, innovative R&D platform. It adopts a combination of quantum physics-based first-principles calculation, AI, high performance cloud computing, and scalable and standardized robotic automation to provide drug and material science R&D solutions and services to global and domestic companies in the pharmaceutical and material science including agritech, energy and new chemicals, and cosmetics industries and beyond.

--

The Group’s business primarily comprises drug discovery solutions providing modular solutions spanning the full spectrum of the drug discovery and research process, and intelligent automation solutions consisting primarily of solid-state R&D services and automated chemical synthesis services.

--

The Group’s customer base includes 16 of the top 20 global biotechnology and pharmaceutical companies ranked by revenue in 2022 according to report. As of December 31, 2023, it also had more than 160 granted patents, approximately 39 ongoing drug discovery programs, and four R&D facilities with more than 10,000 sq.m. of lab space.

BASIC INFORMATION
MarketHong Kong (Main Board)
Business NatureHealth Care
Major Business AreaChina
Board Lot1000
GLOBAL OFFERING
No. of Offer Shares187.37M shares
No. of International Offer Shares149.90M shares
No. of HK Offer Shares37.48M shares
Offer Price$5.03 - $6.03
Stock Code2228
Sponsor(s)CITIC Securities (Hong Kong) Limited
Underwriter(s)CLSA Limited, China International Capital Corporation Hong Kong Securities Limited, Jefferies Hong Kong Limited, Deutsche Bank AG, Hong Kong Branch, CMB International Capital Limited, SPDB International Capital Limited, Guosen Securities (HK) Capital Company Limited, Fosun International Securities Limited, ABCI Securities Company Limited, BOCI Asia Limited, CCB International Capital Limited, ICBC International Securities Limited, Futu Securities International (Hong Kong) Limited, Livermore Holdings Limited, TradeGo Markets Limited
TIME TABLE
Application PeriodJun 04 (Tue) - noon, Jun 07 (Fri)
Price Determination DateJun 11 (Tue)
Result Announcement DateOn or before Jun 12 (Wed)
Result Announcement DateOn or before Jun 12 (Wed)
Result Announcement DateOn or before Jun 13 (Thu)
Dealings in Shares commence onJun 13, 2024. (Thu)
Reallocation of Shares Offered
Times of HK Offer Shares Subscription10X - 50XOver 50X
% of total shares reallocated to HK Offer10%20%
Sales Statistics (HKD)
Offer Price$5.03 - $6.03
Capitalization17.14B - 20.54B
NAV / share ($)$1.52 - $1.58 (Unaudited pro forma adj NAV / share)
Use Of Proceeds
Assuming the offer price being at HKD 5.53, the net proceeds raised would be HKD 941.10M, of which
75% : To continuously enhance R&D capabilities and solutions provision
15% : To improve commercialization capability in and beyond China
10% : Working capital
Related Document
Remark: The above information is referenced from the prospectus.
  All data is calculated from the non- exercise rights(if applicable).
IPO Calculator
Name︰
--
--
--
Subscription --
Result Announcement --
Listing --
Offer Price︰--
Currency :
Listing Price :
Board Lot :
Admission Fee*
:
Subscribing Lot :
Subscribing Fee :

Subscribing Amount :
*Admission fees include brokerage of 1%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.005% and FRC transaction levy of 0.00015% (i.e. 1.0077% in total).
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.